ALEXION PHARMACEUTICALS INC 4
4 · ALEXION PHARMACEUTICALS INC · Filed Dec 15, 2015
Insider Transaction Report
Form 4
NORBY R DOUGLAS
Director
Transactions
- Award
Common Stock, par value $.0001 per share
2015-12-11$26.64/sh+7,932$211,308→ 65,689 total - Award
Common Stock, par value $.0001 per share
2015-12-11$49.43/sh+5,572$275,424→ 71,261 total - Sale
Common Stock, par value $.0001 per share
2015-12-11$187.57/sh−35,575$6,672,803→ 42,314 total - Sale
Common Stock, par value $.0001 per share
2015-12-11$188.24/sh−9,833$1,850,964→ 32,481 total - Award
Common Stock, par value $.0001 per share
2015-12-11$18.01/sh+13,000$234,130→ 45,481 total - Award
Common Stock, par value $.0001 per share
2015-12-11$85.75/sh+3,237$277,573→ 74,498 total - Award
Common Stock, par value $.0001 per share
2015-12-11$16.83/sh+12,276$206,605→ 57,757 total - Award
Common Stock, par value $.0001 per share
2015-12-11$96.35/sh+3,425$329,999→ 77,923 total - Sale
Common Stock, par value $.0001 per share
2015-12-11$186.97/sh−34$6,357→ 77,889 total
Footnotes (3)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $186.00 - $186.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $187.00 - $187.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $188.00 - $188.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.